ClinConnect ClinConnect Logo
Search / Trial NCT04929288

Neural and Hormonal Influences on Sex Differences in Risk for AUD

Launched by JESSICA WEAFER · Jun 9, 2021

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Sex Inhibitory Control Risk Factor Hormone F Mri Menstrual Cycle

ClinConnect Summary

This clinical trial is studying why women may be at a higher risk for Alcohol Use Disorder (AUD) compared to men. Researchers are particularly interested in three areas: how well people can control their impulses (inhibitory control), how negative emotions might influence drinking, and how people react to alcohol-related cues. They hope to uncover the brain and hormonal factors that contribute to these differences, which could lead to better prevention and treatment options specifically designed for women.

To participate in this study, you need to be between 76 and 94 years old, drink alcohol regularly (about 4 to 5 drinks per week), and be fluent in English. It's important that women have regular menstrual cycles and that all participants are right-handed and have completed high school. Some health conditions and medications may disqualify you, so it's best to discuss your medical history with the research team. If you join, you can expect to undergo some tests that look at how your brain functions and how you respond to different emotional situations related to drinking. This research aims to better understand the unique challenges that women face with alcohol use.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • consume 4/5 drinks per week
  • fluent in English
  • high school education
  • right-handed
  • regular menstrual cycles (women)
  • Exclusion Criteria:
  • serious medical problems
  • body weight \<110 or \>210 lbs
  • current medical or psychiatric conditions requiring medication for which alcohol is contraindicated
  • substance use disorder other than alcohol
  • current or recent history of inpatient/intensive treatment for addictive behaviors
  • pregnant, nursing, on hormonal contraception
  • contraindications for fMRI
  • smoking \> 5 cigarettes per day

About Jessica Weafer

Jessica Weafer is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With expertise in orchestrating innovative clinical studies, Jessica fosters collaborations between researchers, healthcare professionals, and regulatory bodies to ensure the integrity and efficacy of trials. Her focus on ethical practices and adherence to regulatory standards underpins a robust framework for developing new therapies. Through meticulous planning and execution, Jessica Weafer is dedicated to contributing valuable insights that will ultimately enhance healthcare solutions and patient care.

Locations

Columbus, Ohio, United States

Lexington, Kentucky, United States

Patients applied

0 patients applied

Trial Officials

Jessica Weafer, PhD

Principal Investigator

Ohio State University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials